Skip to main content
Beta Drugs Limited logo

Beta Drugs Limited — Investor Relations & Filings

Ticker · BETA ISIN · INE351Y01019 LEI · 984500A89888DB9E6T57 National Stock Exchange of India Manufacturing
Open in API
Filings indexed 430 across all filing types
Latest filing 2026-05-25 Share Issue/Capital Cha…
Country IN India
Listing National Stock Exchange of India BETA

About Beta Drugs Limited

https://www.betadrugslimited.com

Beta Drugs Limited specializes in the development, manufacture, and marketing of oncology formulations. The company provides a comprehensive portfolio of anti-cancer drugs across various therapeutic segments, including cytotoxic injectables, lyophilized products, tablets, and capsules. Its manufacturing capabilities encompass a wide range of oncology treatments such as chemotherapy agents and supportive care medications. The organization operates advanced production facilities designed to meet international quality standards, focusing on high-potency active pharmaceutical ingredients and finished dosage forms. The company serves diverse markets through its own branded products and contract manufacturing services, aiming to provide affordable and high-quality cancer care solutions. Its core competency lies in its specialized focus on the oncology niche and its integrated approach to pharmaceutical production.

Recent filings

Filing Released Lang Actions
Outcome of Board Meeting
Share Issue/Capital Change Classification · 85% confidence The document is an announcement under SEBI Listing Regulations of decisions taken at a Board meeting, specifically the allotment of 665,314 equity shares upon conversion of compulsory convertible debentures. This constitutes a share issuance/capital change rather than a management change or full financial report. Therefore, it best fits the “Share Issue/Capital Change” category (SHA).
2026-05-25 English
Analysts/Institutional Investor Meet/Con. Call Updates
Call Transcript Classification · 94% confidence The document is a full Q4 FY26 earnings conference call transcript for Beta Drugs Limited, including moderator introductions, management presentations, financial results, and Q&A. This matches the definition of a call transcript.
2026-05-22 English
Copy of Newspaper Publication
Earnings Release Classification · 75% confidence The document is a statutory submission to the stock exchange containing the newspaper cuttings and the extract of the audited financial results for the quarter and year ended 31 March 2026, with high‐level income and profit figures. It is not a full annual or interim report (no full financial statements, MD&A, or Excel schedules), but rather the initial public announcement of quarterly/annual results. This matches the definition of an Earnings Release (ER). FY 2026
2026-05-16 English
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings
2026-05-15 English
Analysts/Institutional Investor Meet/Con. Call Updates
Investor Presentation Classification · 92% confidence The document is a slide-based corporate presentation titled “FY26 – Annual Result” including strategic priorities, segment breakdowns, detailed FY26 financial performance tables, balance sheet summary, key ratios, and forward-looking statements. It is designed for investors, summarizing strategy, financials, and market positioning. This fits the definition of an Investor Presentation (IP).
2026-05-15 English
Statement of deviation(s) or variation(s) under Reg. 32
Regulatory Filings Classification · 80% confidence The document is a regulatory compliance filing under SEBI Listing Obligations & Disclosure Requirements (Regulation 32) providing a quarterly statement of deviation/variation in the use of preferential issue proceeds. It contains no financial performance data or management discussion, but rather a mandated compliance disclosure. It is not announcing a new report’s publication nor is it a financial report itself, but a routine regulatory announcement. Thus it falls under the general “Regulatory Filings” category (RNS).
2026-05-14 English

Browse filings by year

10 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.